⌘K

Login Start Free

Home/Filings/4/0001179110-15-015239

4//SEC Filing

OSIRIS THERAPEUTICS, INC. 4

Accession 0001179110-15-015239

CIK 0001360886operating

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 5:47 PM ET

Size

6.5 KB

Accession

0001179110-15-015239

Insider Transaction Report

Form 4

Period: 2015-11-18

OSIRIS THERAPEUTICS, INC.OSIR

Danilkovitch Alla

Chief Scientific Officer

Transactions

Exercise/Conversion
Common Stock
2015-11-19$5.08/sh+4,000$20,320→ 11,950 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2015-11-19$5.08/sh−4,000$20,320→ 89,000 total
Exercise: $5.08From: 2013-03-23Exp: 2022-03-23→ Common Stock (4,000 underlying)

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

OSIRIS THERAPEUTICS, INC.

CIK 0001360886

Entity typeoperating

IncorporatedMD

Related Parties

1

filerCIK 0001360886

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 5:47 PM ET
Size: 6.5 KB

View on SEC.gov